The weight-loss-independent benefits of fasting

Benjamin D. Horne

DOI: https://doi.org/10.1038/s42255-024-01012-z

IF: 19.865

2024-03-02

Nature Metabolism

Abstract:In this study in humans, the authors describe distinct phases of adaptions in the plasma proteome to seven days without food, and identify limited associations of protein changes with weight loss.

endocrinology & metabolism

What problem does this paper attempt to address?

Fasting Challenges Human Gut Microbiome Resilience and Reduces Fusobacterium

Yan He,Jia Yin,Jun Lei,Feitong Liu,Huimin Zheng,Shan Wang,Shan Wu,Huafang Sheng,Emily McGovern,Hongwei Zhou

DOI: https://doi.org/10.1016/j.medmic.2019.100003

2019-01-01

Medicine in Microecology

Abstract:Gut microbiome has become a promising target for prediction, prevention and treatment of diseases. It is challenging to modified highly resilient gut microbiome. Diet is one of the determinants of gut microbiome variation. It is intriguing how fasting can affect gut microbiome. Herein, sixteen individuals were recruited with six individuals subjected to a water-only fast and ten individuals receiving a juice fast, both for seven days. Stool samples were collected daily prior to and post fasting. Water-only fasting dramatically changed the bacterial community that participants developed more homogenous gut microbiomes during the fasting period. Conversely, eight out of ten subjects were not significantly affected by juice fasting with no increased homogeneity between participants. Despite the personalized effect of water-only fasting on microbial taxa, relative abundance of Fusobacterium was reduced in four participants who harbored higher Fusobacterium prior to fasting compared to other two participants. Post fasting Fusobacterium remains consistently low across all six individuals. Microbiome changes due to water-only fasting remained in five subjects even after returning to their normal diet, indicating the resilience of gut microbiome was successfully challenged. These results provided preliminary data on how ceasing food intake can shift gut microbiome. Moreover, water only fasting could be a potential tool to reduce Fusobacterium, which promotes colorectal cancer.
Systemic proteome adaptions to 7-day complete caloric restriction in humans

Maik Pietzner,Burulça Uluvar,Kristoffer J. Kolnes,Per B. Jeppesen,S. Victoria Frivold,Øyvind Skattebo,Egil I. Johansen,Bjørn S. Skålhegg,Jørgen F. P. Wojtaszewski,Anders J. Kolnes,Giles S. H. Yeo,Stephen O’Rahilly,Jørgen Jensen,Claudia Langenberg,Stephen O'Rahilly

DOI: https://doi.org/10.1038/s42255-024-01008-9

IF: 19.865

2024-03-02

Nature Metabolism

Abstract:Surviving long periods without food has shaped human evolution. In ancient and modern societies, prolonged fasting was/is practiced by billions of people globally for religious purposes, used to treat diseases such as epilepsy, and recently gained popularity as weight loss intervention, but we still have a very limited understanding of the systemic adaptions in humans to extreme caloric restriction of different durations. Here we show that a 7-day water-only fast leads to an average weight loss of 5.7 kg (±0.8 kg) among 12 volunteers (5 women, 7 men). We demonstrate nine distinct proteomic response profiles, with systemic changes evident only after 3 days of complete calorie restriction based on in-depth characterization of the temporal trajectories of ~3,000 plasma proteins measured before, daily during, and after fasting. The multi-organ response to complete caloric restriction shows distinct effects of fasting duration and weight loss and is remarkably conserved across volunteers with >1,000 significantly responding proteins. The fasting signature is strongly enriched for extracellular matrix proteins from various body sites, demonstrating profound non-metabolic adaptions, including extreme changes in the brain-specific extracellular matrix protein tenascin-R. Using proteogenomic approaches, we estimate the health consequences for 212 proteins that change during fasting across ~500 outcomes and identified putative beneficial (SWAP70 and rheumatoid arthritis or HYOU1 and heart disease), as well as adverse effects. Our results advance our understanding of prolonged fasting in humans beyond a merely energy-centric adaptions towards a systemic response that can inform targeted therapeutic modulation.

endocrinology & metabolism
Efficacy and safety of prolonged water fasting: a narrative review of human trials

Mark Ezpeleta,Sofia Cienfuegos,Shuhao Lin,Vasiliki Pavlou,Kelsey Gabel,Krista A Varady

DOI: https://doi.org/10.1093/nutrit/nuad081

2024-04-12

Abstract:The goal of this narrative review is to summarize the effects of prolonged fasting on various metabolic health measures, including body weight, blood pressure, plasma lipids, and glycemic control. Prolonged fasting is characterized by consciously eating little to no food or caloric beverages for several days to weeks. Results reveal that prolonged fasting for 5-20 days produces potent increases in circulating ketones, and mild to moderate weight loss of 2-10%. Approximately two-thirds of the weight lost is lean mass, and one-third is fat mass. The excessive lean mass loss suggests that prolonged fasting may increase the breakdown of muscle proteins, which is a concern. Systolic and diastolic blood pressure consistently decreased with prolonged fasting. However, the impact of these protocols on plasma lipids is less clear. While some trials demonstrate decreases in LDL cholesterol and triglycerides, others show no benefit. With regard to glycemic control, reductions in fasting glucose, fasting insulin, insulin resistance, and glycated hemoglobin (HbA1c) were noted in adults with normoglycemia. In contrast, these glucoregulatory factors remained unchanged in patients with type 1 or type 2 diabetes. The effects of refeeding were also examined in a few trials. It was shown that 3-4 months after the fast was completed, all metabolic benefits were no longer observed, even when weight loss was maintained. With regard to adverse events, metabolic acidosis, headaches, insomnia, and hunger were observed in some studies. In summary, prolonged fasting appears to be a moderately safe diet therapy that can produce clinically significant weight loss (>5%) over a few days or weeks. However, the ability of these protocols to produce sustained improvements in metabolic markers warrants further investigation.
Weight Loss-Independent Changes in Human Growth Hormone During Water-Only Fasting: A Secondary Evaluation of a Randomized Controlled Trial

Benjamin D. Horne,Jeffrey L. Anderson,Heidi T. May,Tami L. Bair,Viet T. Le,Leslie Iverson,Kirk U. Knowlton,Joseph B. Muhlestein

DOI: https://doi.org/10.1101/2024.05.28.24308055

2024-05-28

Abstract:Introduction: Water-only fasting for one day or more may provide health benefits independent of weight loss. Human growth hormone (HGH) may play a key role in multiple fasting-triggered mechanisms. Whether HGH changes during fasting are independent of weight loss and how basal HGH and HGH change relate to other fasting-induced changes are unknown. Methods: Apparently healthy individuals (N=30) were randomized by Latin square to begin two days with either 24-hour water-only fasting or a control of 24-hour ad libitum eating. On day 2, subjects were crossed over to control (if day 1 was fasting) or fasting (if they ate on day 1). HGH, weight, and other parameters were measured at baseline and at the end of the first and second days. Results: Baseline HGH had median 0.50 ng/mL for females (n=20) and 0.04 ng/mL for males (n=10), and correlated inversely with weight, glucose, insulin, and triglycerides and positively with changes in insulin and HOMA-IR. The 24-hour fasting-induced HGH change was uncorrelated with weight loss (r= 0.01, p=0.98), but correlated with changes in glucose, HGB, and IGF-1. The percent increase in HGH was greater (p<0.001) for lower (females ≤0.15 ng/mL, males ≤0.05 ng/mL) vs. higher baseline HGH (median: 1,225% vs. 50.3%, respectively). Subjects with lower baseline HGH had a trend to greater reduction of HOMA-IR (median: -6.15 vs. -1.35 for lower vs. higher HGH, respectively, p=0.08). Conclusions: Fasting increased HGH and the HGH changes were independent of weight loss. Basal HGH and fasting-induced HGH changes correlated inversely with cardiometabolic risk factors.
Dynamics and ecological reassembly of the human gut microbiome and the host metabolome in response to prolonged fasting

Xiaopu Sang,Shenghui Li,Ruochun Guo,Qiulong Yan,Changxi Liu,Yue Zhang,Qingbo Lv,Lili Wu,Jie Ma,Wei You,Ling Feng,Wen Sun

DOI: https://doi.org/10.3389/fmicb.2023.1265425

IF: 5.2

2023-10-04

Frontiers in Microbiology

Abstract:Introduction: Prolonged fasting is an intervention approach with potential benefits for individuals with obesity or metabolic disorders. Changes in gut microbiota during and after fasting may also have significant effects on the human body. Methods: Here we conducted a 7-days medically supervised water-only fasting for 46 obese volunteers and characterized their gut microbiota based on whole-metagenome sequencing of feces at five timepoints. Results: Substantial changes in the gut microbial diversity and composition were observed during fasting, with rapid restoration after fasting. The ecological pattern of the microbiota was also reassembled during fasting, reflecting the reduced metabolic capacity of diet-derived carbohydrates, while other metabolic abilities such as degradation of glycoproteins, amino acids, lipids, and organic acid metabolism, were enhanced. We identified a group of species that responded significantly to fasting, including 130 fasting-resistant (consisting of a variety of members of Bacteroidetes, Proteobacteria, and Fusobacteria) and 140 fasting-sensitive bacteria (mainly consisting of Firmicutes members). Functional comparison of the fasting-responded bacteria untangled the associations of taxon-specific functions (e.g., pentose phosphate pathway modules, glycosaminoglycan degradation, and folate biosynthesis) with fasting. Furthermore, we found that the serum and urine metabolomes of individuals were also substantially changed across the fasting procedure, and particularly, these changes were largely affected by the fasting-responded bacteria in the gut microbiota. Discussion: Overall, our findings delineated the patterns of gut microbiota alterations under prolonged fasting, which will boost future mechanistic and clinical intervention studies.

microbiology
Effects of intermittent fasting on body composition and clinical health markers in humans

Grant M Tinsley,Paul M La Bounty,Grant M. Tinsley,Paul M. La Bounty

DOI: https://doi.org/10.1093/nutrit/nuv041

2015-09-15

Nutrition Reviews

Abstract:Intermittent fasting is a broad term that encompasses a variety of programs that manipulate the timing of eating occasions by utilizing short-term fasts in order to improve body composition and overall health. This review examines studies conducted on intermittent fasting programs to determine if they are effective at improving body composition and clinical health markers associated with disease. Intermittent fasting protocols can be grouped into alternate-day fasting, whole-day fasting, and time-restricted feeding. Alternate-day fasting trials of 3 to 12 weeks in duration appear to be effective at reducing body weight (≈3%-7%), body fat (≈3-5.5 kg), total cholesterol (≈10%-21%), and triglycerides (≈14%-42%) in normal-weight, overweight, and obese humans. Whole-day fasting trials lasting 12 to 24 weeks also reduce body weight (≈3%-9%) and body fat, and favorably improve blood lipids (≈5%-20% reduction in total cholesterol and ≈17%-50% reduction in triglycerides). Research on time-restricted feeding is limited, and clear conclusions cannot be made at present. Future studies should examine long-term effects of intermittent fasting and the potential synergistic effects of combining intermittent fasting with exercise.

nutrition & dietetics
Intermittent Fasting: Exploring Approaches, Benefits, and Implications for Health and Weight Management

Kathleen Nye,Craig Cherrin,Jan Meires

DOI: https://doi.org/10.1016/j.nurpra.2023.104893

IF: 0.826

2024-02-01

The Journal for Nurse Practitioners

Abstract:Intermittent fasting is an eating pattern that restricts food intake for specific periods. Studies have shown that intermittent fasting can be an effective method for weight loss because it reduces overall calorie intake and increases metabolism. However, consulting a health care professional before starting any new diet or exercise regimen is recommended. This article presents an overview of intermittent fasting, its pathophysiology, associated health benefits, and adverse effects, and provides a guide for the provider in prescribing it.

nursing
Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism

Leonie K Heilbronn,Steven R Smith,Corby K Martin,Stephen D Anton,Eric Ravussin

DOI: https://doi.org/10.1093/ajcn/81.1.69

Abstract:Background: Prolonged dietary restriction increases the life span in rodents. Some evidence suggests that alternate-day fasting may also prolong the life span. Objective: Our goal was to determine whether alternate-day fasting is a feasible method of dietary restriction in nonobese humans and whether it improves known biomarkers of longevity. Design: Nonobese subjects (8 men and 8 women) fasted every other day for 22 d. Body weight, body composition, resting metabolic rate (RMR), respiratory quotient (RQ), temperature, fasting serum glucose, insulin, free fatty acids, and ghrelin were assessed at baseline and after 21 d (12-h fast) and 22 d (36-h fast) of alternate-day fasting. Visual analogue scales were used to assess hunger weekly. Results: Subjects lost 2.5 +/- 0.5% of their initial body weight (P < 0.001) and 4 +/- 1% of their initial fat mass (P < 0.001). Hunger increased on the first day of fasting and remained elevated (P < 0.001). RMR and RQ did not change significantly from baseline to day 21, but RQ decreased on day 22 (P < 0.001), which resulted in an average daily increase in fat oxidation of > or =15 g. Glucose and ghrelin did not change significantly from baseline with alternate-day fasting, whereas fasting insulin decreased 57 +/- 4% (P < 0.001). Conclusions: Alternate-day fasting was feasible in nonobese subjects, and fat oxidation increased. However, hunger on fasting days did not decrease, perhaps indicating the unlikelihood of continuing this diet for extended periods of time. Adding one small meal on a fasting day may make this approach to dietary restriction more acceptable.
From starvation to time-restricted eating: a review of fasting physiology

Candida J. Rebello,Dachuan Zhang,Joseph C. Anderson,Rebecca F. Bowman,Pamela M. Peeke,Frank L. Greenway

DOI: https://doi.org/10.1038/s41366-024-01641-0

2024-10-07

International Journal of Obesity

Abstract:We have long known that subjects with obesity who fast for several weeks survive. Calculations that assume the brain can only use glucose indicated that all carbohydrate and protein sources would be consumed by the brain within several weeks yet subjects with obesity who fasted for several weeks survived. This anomaly led to the determination of the metabolic role of ketone bodies. Subsequent studies transformed our understanding of ketone bodies and illustrated the value of challenging the norm and adapting theory to evidence. Although prolonged fasting is no longer a treatment for obesity, the early studies of starvation provided valuable insights about macronutrient metabolism and ketone body adaptations that fasting elicits. Intermittent fasting and its variants such as time-restricted eating are fasting models that are far less regimented than starvation and severe calorie restriction; yet they produce metabolic benefits. The mechanisms that produce the metabolic changes that intermittent fasting elicits are relatively unknown. In this article, we review the physiology of starvation, starvation adaptation diets, diet-induced ketosis, and intermittent fasting. Understanding the premise and physiology that these regimens induce is necessary to draw parallels and provoke thoughts on the mechanisms underlying the metabolic benefits of intermittent fasting and its variants.

endocrinology & metabolism,nutrition & dietetics
Unveiling the proteome of the fasting heart: Insights into HIF-1 pathway regulation

Daniel Benak,Kristyna Holzerova,Frantisek Kolar,Miloslava Chalupova,Marketa Hlavackova

DOI: https://doi.org/10.3389/fphys.2024.1462014

IF: 4

2024-10-15

Frontiers in Physiology

Abstract:Fasting is a common dietary intervention known for its protective effects against metabolic and cardiovascular diseases. While its effects are mostly systemic, understanding tissue-specific changes in the heart is crucial for the identification of the mechanisms underlying fasting-induced cardioprotection. In this study, we performed a proteomic analysis of the fasting heart and attempted to clarify the molecular basis of fasting-induced cardioprotection. Our investigation identified a total of 4,652 proteins, with 127 exhibiting downregulation and 118 showing upregulation after fasting. Annotation analysis highlighted significant changes in processes such as lipid metabolism, the peroxisome pathway, and reactive oxygen species metabolism. Notably, the HIF-1 signaling pathway emerged as one of the focal points, with various HIF-1 targets exhibiting differential responses to fasting. Further experiments demonstrated downregulation of HIF-1α at both transcript and protein levels. Intriguingly, while gene expression of Egln3 decreased, its protein product PHD3 remained unaffected by fasting. The unchanged levels of pro-inflammatory cytokines indicated that the observed reduction in Hif1a expression did not stem from a decrease in basal inflammation. These findings underscore the complex regulation of the well-established cardioprotective HIF-1 signaling within the heart during 3-day fasting.

physiology
Intermittent Fasting: The Choice for a Healthier Lifestyle

Kavitha Ganesan,Yacob Habboush,Senan Sultan

DOI: https://doi.org/10.7759/cureus.2947

2018-07-09

Cureus

Abstract:Obesity is a worldwide epidemic due to the availability of many unhealthy food options and limited physical exercise. Restriction of the daily food intake results in weight loss, which is also associated with better health outcomes including triglycerides, total cholesterol, low-density lipoprotein cholesterol, blood pressure, glucose, insulin, and C-reactive protein. Our aim is to briefly discuss the effects of intermittent fasting on weight and other biochemical markers mentioned previously. The study is designed as a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. To assess the effectiveness of intermittent fasting, related studies were reviewed between 2000 and 2018 and 815 studies were identified. Only four articles met the preset inclusion and exclusion criteria. All four studies have shown a significant decrease in fat mass with P-values <0.01. It was also noted that some biochemical markers were significantly reduced such as the reduction in low-density lipoprotein and triglyceride with P-values < 0.05. Other biochemical markers had inconsistent results. Based on the qualitative analysis, intermittent fasting was found to be efficient in reducing weight, irrespective of the body mass index. Further studies are needed to assess the ability to maintain the lost weight without regaining it and the long-term effects of such dietary changes.
Intermittent fasting for obesity and related disorders: unveiling myths, facts, and presumptions

Bruno Halpern,Thiago Bosco Mendes

DOI: https://doi.org/10.20945/2359-3997000000322

2021-01-18

Archives of Endocrinology and Metabolism

Abstract:Intermittent fasting (IF) is an increasingly popular method of weight loss, as an alternative to daily caloric restriction (DCR). Several forms of IF exist, such as alternate-day fasting or time-restricted feeding regimens. Some of its proponents claim several health benefits unrelated to caloric restriction or weight loss, which rely mainly on animal models. Although several studies published in the last few years confirm that IF can be a useful and safe therapeutical option for obesity and related disorders, no superiority to conventional caloric restriction diets have emerged. There are still several questions left answered. In this Review, we discuss some of the claims, unveiling myths, facts, and presumptions about several models of IF. The focus of this article is obesity, but there is a brief discussion of the potential benefits of IF on overall human health.
Influence of Long-Term Fasting on Blood Redox Status in Humans

Françoise Wilhelmi de Toledo,Franziska Grundler,Nikolaos Goutzourelas,Fotios Tekos,Eleni Vassi,Robin Mesnage,Demetrios Kouretas

DOI: https://doi.org/10.3390/antiox9060496

IF: 7.675

2020-06-06

Antioxidants

Abstract:Fasting is increasingly practiced to improve health and general well-being, as well as for its cytoprotective effects. Changes in blood redox status, linked to the development of a variety of metabolic diseases, have been recently documented during calorie restriction and intermittent fasting, but not with long-term fasting (LF). We investigated some parameters of the blood redox profile in 109 subjects before and after a 10-day fasting period. Fasting resulted in a significant reduction in body weight, improved well-being and had a beneficial modulating effect on blood lipids and glucose regulation. We observed that fasting decreased lipid peroxidation (TBARS) and increased total antioxidant capacity (TAC) in plasma, concomitant with a uric acid elevation, known to be associated with fasting and did not cause gout attacks. Reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPx) and catalase in erythrocytes did not show significant changes. In addition, reduction in body weight, waist circumference, and glucose levels were associated to a reduced lipid peroxidation. Similar results were obtained by grouping subjects on the basis of the changes in their GSH levels, showing that a period of 10 days fasting improves blood redox status regardless of GSH status in the blood.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Long-term fasting remodels gut microbial metabolism and host metabolism

QR Ducarmon,F Grundler,C Giannopoulou,A Loumé,N Karcher,M Larralde,S Romano,MR MacArthur,SJ Mitchell,F Wilhelmi de Toledo,G Zeller,R Mesnage

DOI: https://doi.org/10.1101/2024.04.19.590209

2024-04-19

Abstract:Long-term fasting has become a promising research subject for its potential of treating and preventing metabolic diseases. However, little is known about its impact on the functional capacity of the gut microbiome and the combined effect on the serum metabolome. Here, we demonstrate extensive remodelling of the gut microbial ecosystem in humans (n=92) after an average of 9.8 days of fasting (∼250 kcal / day). Fasting transiently affected the relative abundance of the majority of bacterial species (306 decreased and 210 increased out of 772). Species changes could largely be explained by their genomic repertoire of carbohydrate-active enzymes (CAZymes), which were investigated here for the first time. Fasting induced extensive abundance changes in CAZyme families, depleting families with dietary fibre substrates and increasing families with host-derived glycan substrates. Likewise, we observed extensive changes in the serum metabolome, with 382 out of 721 metabolites significantly affected (246 increased and 136 decreased). In-depth metagenome-metabolome co-variation analysis suggested species to be key producers of indole-3-propionic acid, a crucial metabolite for cardiometabolic health. Together, our results provide an unprecedented view on the impact of long-term fasting on gut microbiome composition and function.

Microbiology
Effect of an acute fast on energy compensation and feeding behaviour in lean men and women

AM Johnstone,P Faber,ER Gibney,M Elia,G Horgan,BE Golden,RJ Stubbs

DOI: https://doi.org/10.1038/sj.ijo.0802151

2002-12-01

International Journal of Obesity

Abstract:AIM: Humans appear to defend against energy deficit to a greater extent than energy surplus. Severe dietary energy restriction resulting in 5–30% weight loss often leads to hyperphagia and weight regain in lean subjects. However, the period of time over which fasting is often endured in Western society are far shorter, ∼1–2 days. This study examined how a 36 h fast effected the subsequent day's energy and nutrient intake in a group of 24 healthy, lean men and women.METHOD: Subjects underwent two 2 day treatments, termed ‘fast’ and ‘maintenance’. During the ‘fast’ treatment, subjects were fed a maintenance diet on the day prior to the fast (day −1) to prevent overeating. They then consumed non-energy drinks only, from 20:00 h on day −1 to 08:00 h on day 2 (ad libitum feeding day), thus fasting for 36 h. On the ‘maintenance’ protocol, subjects received a maintenance diet throughout day 1. Throughout day 2 they had ad libitum access to a range of familiar foods, which were the same for both treatments. Body weight, blood glucose and respiratory quotient were used as compliance checks. Hunger was monitored on day's −1, 1 and 2 for the fast treatment only.RESULTS: On day 2, average energy intake was 10.2 vs 12.2 MJ/day (s.e.d. 1.0) on the post-maintenance and post-fast periods, respectively (P=0.049). Subjects altered feeding behaviour, in response to the fast, only at breakfast time, selecting a higher-fat meal (P<0.005). Compared to day −1, motivation to eat was elevated during the fast (P<0.05). This continued until breakfast was consumed during the re-feeding period (day 2), when values then returned to baseline.CONCLUSION: These data suggest that a 36 h fast, which generated a negative energy balance of ∼12 MJ, did not induce a powerful, unconditioned stimulus to compensate on the subsequent day.

endocrinology & metabolism,nutrition & dietetics
Impact of intermittent fasting on health and disease processes

Mark P. Mattson,Valter D. Longo,Michelle Harvie

DOI: https://doi.org/10.1016/j.arr.2016.10.005

IF: 11.788

2017-10-01

Ageing Research Reviews

Abstract:Humans in modern societies typically consume food at least three times daily, while laboratory animals are fed ad libitum. Overconsumption of food with such eating patterns often leads to metabolic morbidities (insulin resistance, excessive accumulation of visceral fat, etc.), particularly when associated with a sedentary lifestyle. Because animals, including humans, evolved in environments where food was relatively scarce, they developed numerous adaptations that enabled them to function at a high level, both physically and cognitively, when in a food-deprived/fasted state. Intermittent fasting (IF) encompasses eating patterns in which individuals go extended time periods (e.g., 16-48h) with little or no energy intake, with intervening periods of normal food intake, on a recurring basis. We use the term periodic fasting (PF) to refer to IF with periods of fasting or fasting mimicking diets lasting from 2 to as many as 21 or more days. In laboratory rats and mice IF and PF have profound beneficial effects on many different indices of health and, importantly, can counteract disease processes and improve functional outcome in experimental models of a wide range of age-related disorders including diabetes, cardiovascular disease, cancers and neurological disorders such as Alzheimer's disease Parkinson's disease and stroke. Studies of IF (e.g., 60% energy restriction on 2days per week or every other day), PF (e.g., a 5day diet providing 750-1100kcal) and time-restricted feeding (TRF; limiting the daily period of food intake to 8h or less) in normal and overweight human subjects have demonstrated efficacy for weight loss and improvements in multiple health indicators including insulin resistance and reductions in risk factors for cardiovascular disease. The cellular and molecular mechanisms by which IF improves health and counteracts disease processes involve activation of adaptive cellular stress response signaling pathways that enhance mitochondrial health, DNA repair and autophagy. PF also promotes stem cell-based regeneration as well as long-lasting metabolic effects. Randomized controlled clinical trials of IF versus PF and isoenergetic continuous energy restriction in human subjects will be required to establish the efficacy of IF in improving general health, and preventing and managing major diseases of aging.

cell biology,geriatrics & gerontology,gerontology
Clinical application of intermittent fasting for weight loss: progress and future directions

Krista A. Varady,Sofia Cienfuegos,Mark Ezpeleta,Kelsey Gabel

DOI: https://doi.org/10.1038/s41574-022-00638-x

2022-02-22

Nature Reviews Endocrinology

Abstract:Nature Reviews Endocrinology, Published online: 22 February 2022; doi:10.1038/s41574-022-00638-xIntermittent fasting diets are increasingly popular alternatives to traditional weight loss methods; however, their efficacy and safety are currently unclear. This Review evaluates the current research on intermittent fasting and discusses the benefits and challenges of these diets.

endocrinology & metabolism
Abstract P2072: Integrative Network Analysis Of Microbiome-Immune Axis In Metabolic Syndrome Patients During A Fasting Intervention

Ellen G Avery,András Balogh,Hendrik Bartolomaeus,Ulrike Löber,Nico Steckhan,Lajos Markó,Nicola Wilck,Ibrahim Hamad,Urša Šušnjar,Anja Mähler,Christoph Hohmann,Till R Lesker,Till Strowig,Ralf Dechend,Danilo Bzdok,Markus Kleinewietfeld,Andreas Michalsen,Dominik N Müller,Sofia K Forslund

DOI: https://doi.org/10.1161/hyp.74.suppl_1.p2072

IF: 9.8968

2019-09-01

Hypertension

Abstract:Fasting can prolong survival and reduce disease burden in rodent models, and possibly in humans. The relationship between diet, gut microbiota, immune system and host (patho)physiology has only recently been explored, and information is lacking on how periodic fasting affects the gut microbiome in patients with metabolic syndrome (MetS). We show a 5-day fast (FAST) in humans, followed by a modified DASH diet is more effective than DASH alone (DASH) at reducing systolic blood pressure (SBP change measured by ABPM, 95% CI; FAST: [-7.053,-1.142], DASH: [-5.880,1.477]), need for antihypertensive medication (FAST: n=15 of n=35, DASH: n=6 of n=36 patients), and body-mass index at three months post intervention. Fasting altered the gut microbiome, impacting bacterial taxa and functional gene modules associated with the production of short-chain fatty acids (e.g. Faecalibacterium prausnitzii , Eubacterium rectale, Coprococcus comes ), previously linked to vascular health and immunity. Immunophenotyping and cross-system analyses revealed that SBP changes correlated with circulating Il-2 + TNFα + mucosa-associated invariant T (MAIT) cells (FDR-corr P(q) =0.044, Spearman’s rho=0.44), Il-17 - IFNγ + MAITs (FDR-corr P(q) =0.022, Spearman’s rho=0.49), and effector CD4 + T cells (FDR-corr P(q)=0.047, Spearman’s rho=0.43). By stratifying the fasting group into BP responders and non-responders, we identified a set of 76 microbial and 99 immune responder-specific features. Machine learning algorithms could predict long-term SBP responsiveness from baseline immunome data, identifying changes in effector CD8 + T cells, Th17 cells and Tregs as discriminators (Single-subject prediction: 71%). This is the first high-resolution multi-omics characterization of fasting in MetS. Fasting induced long-term reduction in body weight and SBP, accompanied by changes in microbiome and immune homeostasis. Our data implicate fasting as a promising non-pharmacological intervention in MetS.

peripheral vascular disease
Fasting the Microbiota to Improve Metabolism?

Joel T. Haas,Bart Staels

DOI: https://doi.org/10.1016/j.cmet.2017.09.013

IF: 29

2017-10-01

Cell Metabolism

Abstract:While intermittent or periodic fasting provides a variety of favorable health benefits, the molecular mediators of these effects are poorly understood. In this issue of Cell Metabolism, Li and colleagues (2017) highlight the role of gut microbiota in mediating benefits of intermittent fasting through activation of adipose tissue beiging.

cell biology,endocrinology & metabolism
Intermittent Fasting: Is the Wait Worth the Weight?

Mary-Catherine Stockman,Dylan Thomas,Jacquelyn Burke,Caroline M. Apovian

DOI: https://doi.org/10.1007/s13679-018-0308-9

2018-04-26

Current Obesity Reports

Abstract:Purpose of ReviewWe review the underlying mechanisms and potential benefits of intermittent fasting (IF) from animal models and recent clinical trials.Recent FindingsNumerous variations of IF exist, and study protocols vary greatly in their interpretations of this weight loss trend. Most human IF studies result in minimal weight loss and marginal improvements in metabolic biomarkers, though outcomes vary. Some animal models have found that IF reduces oxidative stress, improves cognition, and delays aging. Additionally, IF has anti-inflammatory effects, promotes autophagy, and benefits the gut microbiome. The benefit-to-harm ratio varies by model, IF protocol, age at initiation, and duration.SummaryWe provide an integrated perspective on potential benefits of IF as well as key areas for future investigation. In clinical trials, caloric restriction and IF result in similar degrees of weight loss and improvement in insulin sensitivity. Although these data suggest that IF may be a promising weight loss method, IF trials have been of moderate sample size and limited duration. More rigorous research is needed.

endocrinology & metabolism,nutrition & dietetics

The weight-loss-independent benefits of fasting

Fasting Challenges Human Gut Microbiome Resilience and Reduces Fusobacterium

Systemic proteome adaptions to 7-day complete caloric restriction in humans

Efficacy and safety of prolonged water fasting: a narrative review of human trials

Weight Loss-Independent Changes in Human Growth Hormone During Water-Only Fasting: A Secondary Evaluation of a Randomized Controlled Trial

Dynamics and ecological reassembly of the human gut microbiome and the host metabolome in response to prolonged fasting

Effects of intermittent fasting on body composition and clinical health markers in humans

Intermittent Fasting: Exploring Approaches, Benefits, and Implications for Health and Weight Management

Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism

From starvation to time-restricted eating: a review of fasting physiology

Unveiling the proteome of the fasting heart: Insights into HIF-1 pathway regulation

Intermittent Fasting: The Choice for a Healthier Lifestyle

Intermittent fasting for obesity and related disorders: unveiling myths, facts, and presumptions

Influence of Long-Term Fasting on Blood Redox Status in Humans

Long-term fasting remodels gut microbial metabolism and host metabolism

Effect of an acute fast on energy compensation and feeding behaviour in lean men and women

Impact of intermittent fasting on health and disease processes

Clinical application of intermittent fasting for weight loss: progress and future directions

Abstract P2072: Integrative Network Analysis Of Microbiome-Immune Axis In Metabolic Syndrome Patients During A Fasting Intervention

Fasting the Microbiota to Improve Metabolism?

Intermittent Fasting: Is the Wait Worth the Weight?